Montpellier Fr. - Sim&Cure, a medical technology company focuses on the development and commercialization of a simulation software, Sim&Size®, for devices treating patients with cerebral aneurysm. The simulation can be done during the intervention or pre-intervention.
The CE Mark approval is a significant accomplishment for Sim&Cure as this application required rigorous regulatory review against clinical and safety standards. The CE approval enables the company to market and sell Sim&Size® in the European Union (EU) member countries. The company plans to make Sim&Size® available to all neurointerventional devices.
Sim&Size® offers at the moment two first CE marked modules dedicated to flowdiverters and intrasaccular devices.
FDsize® simulates the deployment and sizing of flowdiverter; IDsize® simulates the deployment and sizing of intrasaccular devices.
The software platform will soon integrate a third module STsize, that simulates the deployment and sizing of intracranial laser-cut devices.
In a near future, Sim&Size will allow neurointerventionists to perform a full virtual therapeutic planning with all intracranial devices available on the market.